4.2 Review

Super-SILAC: current trends and future perspectives

Journal

EXPERT REVIEW OF PROTEOMICS
Volume 12, Issue 1, Pages 13-19

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14789450.2015.982538

Keywords

biomarkers; cancer; clinical proteomics; mass spectrometry; quantitative proteomics; spike-in standard; stable isotope labeling; super-SILAC

Funding

  1. Israel Cancer Research Fund
  2. Israel Science Foundation-Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease Center [41/11]

Ask authors/readers for more resources

Stable isotope labeling with amino acids in cell culture (SILAC) has risen as a powerful quantification technique in mass spectrometry (MS)-based proteomics in classical and modified forms. Previously, SILAC was limited to cultured cells because of the requirement of active protein synthesis; however, in recent years, it was expanded to model organisms and tissue samples. Specifically, the super-SILAC technique uses a mixture of SILAC-labeled cells as a spike-in standard for accurate quantification of unlabeled samples, thereby enabling quantification of human tissue samples. Here, we highlight the recent developments in super-SILAC and its application to the study of clinical samples, secretomes, post-translational modifications and organelle proteomes. Finally, we propose super-SILAC as a robust and accurate method that can be commercialized and applied to basic and clinical research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available